Directed issue Sep 2020

The directed issue was carried out on the basis of the registered issue authorization that the Annual General Meeting of Cereno Scientific AB decided on 10 June 2020.

Short summary:

  • The Company has carried out a directed issue of 15,800,000 units. One unit will consist of two (2) shares of series B and two (2) warrants. Of the warrants, one (1) warrant will be of series TO1 and one (1) warrant will be of series TO2.
  • The directed issue has been targeted to a limited group of qualified investors.
  • Additionally, the Company will issue and allocate two (2) warrants of series TO1 and two (2) warrants of series TO2 respectively to current shareholders for every five (5) shares owned on the applicable record date.
  • The subscription price in the directed issue was set to SEK 3.80 per unit, corresponding to SEK 1.90 per share. The warrants are issued and allotted free of charge.
  • Through the directed issue, the Company will initially receive approximately SEK 60 million before deduction of transaction costs.
  • The Company's Board of Directors has also entered into a loan financing agreement of SEK 10 million with Formue Nord Fokus A/S, whom also will receive warrants of series TO1 and TO2.

Information

Press release9 October 2020

First day of trading in warrants of series TO1 and TO2 has been set for October 14, 2020

Read here >

Press release2 October 2020

Record date for distribution of warrants of series TO1 and TO2 to current shareholders is set for October 9, 2020

Read here >

Press release30 September 2020

Cereno Scientific AB completes a directed issue of units of approximately SEK 60 million and issues warrants to current shareholders

Read here >

Press release29 September 2020

Cereno Scientific AB intends to carry out a directed issue of units and enters into a loan agreement

Read here >

Documents

Terms and Conditions for Warrants of series TO1

Read here >

Terms and Conditions for Warrants of series TO2

Read here >